Top Markets
Coin of the day
Pharmena S.a. Pharmena S.a.

Pharmena S.a.

PHR
Rang in aandelen #32511
Pharmena S.A. engages in the sale of dietary supplements in Poland and... Pharmena S.A. engages in the sale of dietary supplements in Poland and internationally. It also develops 1-MNA (PHR-701 program), a medical device for use in difficult-to-heal wounds. In addition, the company is involved in research and development of therapeutic applications of 1 MNA as an anti-inflammatory and anti-fibrotic drug; and research and development at pulmonary fibrosis, respiratory tract infections, including viral infections, COVID-19, inflammatory diseases, metabolic diseases and other therapeutic applications. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. operates as a subsidiary of Pelion S.A.
Aandeelprijs
$0.88679187
Laatst gesynchroniseerd: 2026-08-17
Marktkapitalisatie
$9.88M
Verandering (1 dag)
-1.56%
Verandering (1 jaar)
-7.71%
Land
PL
Handel Pharmena S.a. (PHR)

Categorie

Dividendrendementgeschiedenis voor Pharmena S.a. (PHR)
Het dividendrendement (TTM) van Pharmena S.a. (aandelsymbool: PHR) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Pharmena S.a. (PHR) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten